Pratik Shah's Trading History
| SPRYARS Pharmaceuticals | Nov 14, 2025 | Director | Uninformative Sell | ― | $15.12M | |
| DSGNDesign Therapeutics | Apr 01, 2021 | President, CEO and Chairperson, Director | Informative Buy | 500.00K | $1.65M | |
| ~~THORSynthorx | Jan 24, 2020 | ― | Uninformative Sell | 4.24M | $0.00 | |
| ASPXAuspex Pharma | May 05, 2015 | ― | Uninformative Sell | ― | ― | |
| OCRXOcera Therapeutics | Jul 17, 2013 | ― | Uninformative Buy | ― | $4.48M |
You May Also Like
Pratik Shah insider profile FAQ
What is the percentage of profitable transactions made by Pratik Shah?
The percentage of profitable transactions made by Pratik Shah is 50%.
What is the average return per transaction made by Pratik Shah?
The average return per transaction made by Pratik Shah is 70.60%.
What stocks does Pratik Shah hold?
Pratik Shah holds: SPRY, ASPX, ~~THOR, DSGN, OCRX stocks.
What was Pratik Shah's most profitable transaction?
Pratik Shah’s most profitable transaction was an Informative Buy of ASPX stock on February 12, 2014. The return on the trade was 183.70%.
What is Pratik Shah's role in ARS Pharmaceuticals?
Pratik Shah's role in ARS Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.